Back to search
FDAFDA · Food and drugs·Recall number D-0326-2017

TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21

Published January 11, 2017 · Recall initiated: December 22, 2016

Summary

FDA records drug Class III recall D-0326-2017, published January 11, 2017 and initiated December 22, 2016. Recalling firm: Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals; Status: Terminated; Reported quantity: 1200 bottles; Lot: T248H15A, Exp. 08/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals
Distributor
Nationwide
Lot
T248H15A, Exp. 08/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21 recalled?

Yes. FDA published recall D-0326-2017 on January 11, 2017. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter